BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Root-Bernstein R. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death. Vaccines (Basel) 2020;8:E559. [PMID: 32987794 DOI: 10.3390/vaccines8040559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Root-Bernstein R. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines (Basel) 2021;9:474. [PMID: 34066697 DOI: 10.3390/vaccines9050474] [Reference Citation Analysis]
2 Touati R, Elngar AA. Intelligent system based comparative analysis study of SARS-CoV-2 spike protein and antigenic proteins in different types of vaccines. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00216-0] [Reference Citation Analysis]
3 Camoretti-Mercado B, Liao Q, Tian Z, Allen-Gipson D. Editorial: Cigarette Smoke, E-Cigarette/E-Vaping and COVID-19: Risks and Implications in This New Era. Front Physiol 2021;12:724910. [PMID: 34566686 DOI: 10.3389/fphys.2021.724910] [Reference Citation Analysis]
4 Root-Bernstein R. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int J Mol Sci 2021;22:2108. [PMID: 33672738 DOI: 10.3390/ijms22042108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sałkowska A, Karwaciak I, Karaś K, Dastych J, Ratajewski M. SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors. Vaccines (Basel) 2020;8:E673. [PMID: 33198287 DOI: 10.3390/vaccines8040673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Demirci I, Haymana C, Salman S, Tasci I, Corapcioglu D, Kirik A, Yetkin İ, Altay M, Sabuncu T, Bayram F, Satman I, Sonmez A, TEMD Study Group. Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study). World J Diabetes 2021; 12(12): 2107-2118 [DOI: 10.4239/wjd.v12.i12.2107] [Reference Citation Analysis]
7 Sumbul B, Sumbul HE, Okyay RA, Gülümsek E, Şahin AR, Boral B, Koçyiğit BF, Alfishawy M, Gold J, Tasdogan AM. Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study. PeerJ 2021;9:e10910. [PMID: 33614298 DOI: 10.7717/peerj.10910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 McIntosh EDG, Feemster K, Rello J. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2. Hum Vaccin Immunother 2021;:1-7. [PMID: 34406914 DOI: 10.1080/21645515.2021.1957647] [Reference Citation Analysis]
9 Altulayhi RI, Alqahtani RM, Alakeel RA, Khorshid FA, Alshammari RH, Alattas SG, Alshammari FAM, Bin-Jumah M, Abdel-Daim MM, Almohideb M. Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study. Environ Sci Pollut Res Int 2021. [PMID: 34184228 DOI: 10.1007/s11356-021-14980-6] [Reference Citation Analysis]
10 Root-Bernstein R. COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors. Bioessays 2021;43:e2100158. [PMID: 34677872 DOI: 10.1002/bies.202100158] [Reference Citation Analysis]
11 Singh J, Alam A, Samal J, Maeurer M, Ehtesham NZ, Chakaya J, Hira S, Hasnain SE. Role of multiple factors likely contributing to severity-mortality of COVID-19. Infect Genet Evol 2021;96:105101. [PMID: 34624542 DOI: 10.1016/j.meegid.2021.105101] [Reference Citation Analysis]
12 Zaman MS, Sizemore RC. Diverse Manifestations of COVID-19: Some Suggested Mechanisms. Int J Environ Res Public Health 2021;18:9785. [PMID: 34574709 DOI: 10.3390/ijerph18189785] [Reference Citation Analysis]
13 Haque A, Pant AB. Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines (Basel) 2020;8:E739. [PMID: 33291245 DOI: 10.3390/vaccines8040739] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
14 Razim A, Pacyga K, Naporowski P, Martynowski D, Szuba A, Gamian A, Górska S. Identification of linear epitopes on the flagellar proteins of Clostridioides difficile. Sci Rep 2021;11:9940. [PMID: 33976336 DOI: 10.1038/s41598-021-89488-7] [Reference Citation Analysis]